Search

for
Search:

Research

5 / 1000+ results

Injectable Platelet-Rich Fibrin Promotes Proliferation and Trichogenic Inductivity of Dermal Papilla Cells Through Activating TGF-β/Smad Signaling Pathway

research Injectable platelet-rich fibrin promotes proliferation and trichogenic inductivityof dermal papilla cells through activating TGF-β/Smad signaling pathway

4 citations , April 2024 in “Cellular and Molecular Biology”

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Human Bone Marrow Mesenchymal Stem Cells-Derived Exosomes Stimulate Cutaneous Wound Healing Mediated Through TGF-β/Smad Signaling Pathway

research Human bone marrow mesenchymal stem cells-derived exosomes stimulate cutaneous wound healing mediates through TGF-β/Smad signaling pathway

April 2020 in “Research Square (Research Square)”

Exosomes from stem cells help wounds heal faster by affecting specific cell signals.

Network Pharmacology and In Vivo Experimental Analysis for Validating the Antifibrotic Potential of Punica Granatum Leaves Against Skin Scleroderma: The Role of Oxidative Stress, Inflammation and TGF-β1/Snail 1/p-Smad 3 Signaling Pathway

research Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway

April 2026 in “Inflammopharmacology”

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

ECM1 Modified HF-MSCs Targeting HSC Attenuate Liver Cirrhosis by Inhibiting the TGF-β/Smad Signaling Pathway

research ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway

18 citations , February 2022 in “Cell Death Discovery”

ECM1-modified stem cells can effectively treat liver cirrhosis.

iTRAQ-Based Quantitative Proteomics Revealing the Therapeutic Mechanism of a Medicinal and Edible Formula YH0618 in Reducing Doxorubicin-Induced Alopecia by Targeting Keratins and TGF-β/Smad3 Pathway

research iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway

June 2024 in “Heliyon”

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

View more "tgf-v smad3 pathway" in research →

Clinics

6 / 14 results

All 14 clinic results →

Experts

6 / 9 results

All 9 expert results →

Learn

— no results

Try a deeper search in learn →

Community Join

— no results

Try a deeper search in community →